This book discusses essential aspects of diabetic foot ulcers, including evidence-based information on its pathogenesis and pathophysiology, as well as the molecular mechanisms and biomechanics of the diabetic foot. It also highlights the need for a multidisciplinary team to be involved in the management of diabetic patients with foot ulcers, and describes available and future tools for evaluating patients who are at risk. Exploring the main current therapies as well as the latest developments, future directions and potential new treatments, such as growth factors, stem cell therapy,…mehr
This book discusses essential aspects of diabetic foot ulcers, including evidence-based information on its pathogenesis and pathophysiology, as well as the molecular mechanisms and biomechanics of the diabetic foot. It also highlights the need for a multidisciplinary team to be involved in the management of diabetic patients with foot ulcers, and describes available and future tools for evaluating patients who are at risk. Exploring the main current therapies as well as the latest developments, future directions and potential new treatments, such as growth factors, stem cell therapy, alternative medicine and nanotechnology, the book is a valuable resource for clinicians and medical graduates but will also appeal to researchers working in the field.
Dr Mohammad Zubair is an Assistant Professor at the Department of Medical Microbiology, Faculty of Medicine, University of Tabuk, Kingdom of Saudi Arabia. He completed his PhD and post-doctorate research on diabetic foot infections and has extensive teaching and research experience in the field of medical science. His research focuses on the extended spectrum beta-lactamase gene (CTX, TEM & SHV), pro and anti-inflammatory cytokines and healing proteins and their clinical correlations. He has published more than 35 papers in international, peer-reviewed journals, and has presented his work at various international conferences. He is also the recipient of one of the prestigious "Marvil Levin" research awards presented by the American Diabetes Association (ADA) at the 72nd Scientific Session held at Philadelphia, USA. Dr Jamal Ahmad is a former Professor of Endocrinology; ex Dean of the Faculty of Medicine, J.N. Medical College; and ex Director of the Rajiv Gandhi Centre for Diabetes & Endocrinology, Faculty of Medicine, Aligarh Muslim University, India. He has made a significant contribution toward determining the role of protein glycation in diabetes and its associated complications. He has published more than 240 research articles in various international and national journals, was Principal Investigator or Co-Investigator in a number of research projects, and has completed 9 phase III international, multi-centre, multicounty new drug trials in diabetes mellitus. He is a former President of the Endocrine Society of India, and the recipient of the prestigious RSSDI fellowship-2015 and a Lifetime Achievement Award by Diabetes India 2019. Dr Abida Malik is a former Professor and Chairperson of the Department of Microbiology, and the former Dean of the Faculty of Medicine, Jawaharlal Nehru Medical College, Aligarh Muslim University. A leading Indian microbiologist, she has over 41 years of teaching and research experience and authored more that 185 publications. She established the Virology Lab in 1976, Mycology lab in 1980 and was founded and was responsible for the AIDS Surveillance Centre for 20 years. She is the former president of the Indian Association of Microbiologists, and received the Dr UC Chaturvedi Life Time achievement Award for her services to microbiology in 2011. Dr. Mallikrjuna Rao. Talluri is currently a Research Associate at AXIS Clinicals Limited, Hyderabad, India, where his work focuses on development methods and the quantification of new drugs and their bioavailability and bioequivalence. He is an expert on the evaluation of the biological activities of natural products (bio-guided extraction), and scientific writing, and has experience in instrumental handling, such as LC-MS/MS, HPLC, column chromatography, and TLC. He has worked extensively in the field of phytopharmacology, and has published more than 50 papers in peer-reviewed, international and national journals.
Inhaltsangabe
Part I: World Preview.- Chapter 1. Diabetic-Foot Complications in Asian & European Continents.- Chapter 2. Diabetic-Foot Complications in African and Antarctica Continents.- Chapter 3. Diabetic-Foot Complications in American and Australian Continents.- Part II: Complications & Treatments Updates.- Chapter 4. Acute and Chronic Wound Healing Physiology.- Chapter 5. Screening of Foot Inflammation in Diabetic Patients by Non-invasive Imaging Modalities.- Chapter 6. Molecular Mechanism & BioMechanics of the Diabetic Foot: The Road to Foot Ulceration and Healing.- Chapter 7. Foot Pressure Abnormalities, Radiographic and Charcot Changes in the Diabetic Foot.- Chapter 8. Aerobic and Anaerobic Bacterial Infections and Treatment Strategies.- Chapter 9. MRSA, EBSL and Biofilm formation in Diabetic Foot Ulcer Infections.- Chapter 10. Fungal infection: the hidden enemy?.- Chapter 11. Diabetic Foot Syndrome: Risk Factors, Clinical Assessment, and Advances in Diagnosis.- Part III Developments, Futureprospective, New Possible Treatments.- Chapter 12. Advances in Prevention and Empirical Treatment of Diabetic Foot Infection.- Chapter 13. Prevention of Diabetic Foot: Indian Experience.- Chapter 14. Low Cost Management in Diabetic Foot.- Chapter 15. Role of Growth Factors in the Treatment of Diabetic Foot Ulceration.- Chapter 16. Stem cells in the Treatment of Diabetic Foot Ulcers.- Chapter 17. Alternative Medicine in the Management of Diabetic Foot Ulcers/Infections.- Chapter 18. Modern Phytomedicine in Treating Diabetic Foot Ulcer: Progress and Opportunities.- Chapter 19. Management of Diabetic Foot Ulcer by Hirudo medicinalis, the 'healing leech'.- Chapter 20. Nanotechnology and Diabetic Foot Ulcer: Future prospects.
Part I: World Preview.- Chapter 1. Diabetic-Foot Complications in Asian & European Continents.- Chapter 2. Diabetic-Foot Complications in African and Antarctica Continents.- Chapter 3. Diabetic-Foot Complications in American and Australian Continents.- Part II: Complications & Treatments Updates.- Chapter 4. Acute and Chronic Wound Healing Physiology.- Chapter 5. Screening of Foot Inflammation in Diabetic Patients by Non-invasive Imaging Modalities.- Chapter 6. Molecular Mechanism & BioMechanics of the Diabetic Foot: The Road to Foot Ulceration and Healing.- Chapter 7. Foot Pressure Abnormalities, Radiographic and Charcot Changes in the Diabetic Foot.- Chapter 8. Aerobic and Anaerobic Bacterial Infections and Treatment Strategies.- Chapter 9. MRSA, EBSL and Biofilm formation in Diabetic Foot Ulcer Infections.- Chapter 10. Fungal infection: the hidden enemy?.- Chapter 11. Diabetic Foot Syndrome: Risk Factors, Clinical Assessment, and Advances in Diagnosis.- Part III Developments, Futureprospective, New Possible Treatments.- Chapter 12. Advances in Prevention and Empirical Treatment of Diabetic Foot Infection.- Chapter 13. Prevention of Diabetic Foot: Indian Experience.- Chapter 14. Low Cost Management in Diabetic Foot.- Chapter 15. Role of Growth Factors in the Treatment of Diabetic Foot Ulceration.- Chapter 16. Stem cells in the Treatment of Diabetic Foot Ulcers.- Chapter 17. Alternative Medicine in the Management of Diabetic Foot Ulcers/Infections.- Chapter 18. Modern Phytomedicine in Treating Diabetic Foot Ulcer: Progress and Opportunities.- Chapter 19. Management of Diabetic Foot Ulcer by Hirudo medicinalis, the 'healing leech'.- Chapter 20. Nanotechnology and Diabetic Foot Ulcer: Future prospects.
Es gelten unsere Allgemeinen Geschäftsbedingungen: www.buecher.de/agb
Impressum
www.buecher.de ist ein Internetauftritt der buecher.de internetstores GmbH
Geschäftsführung: Monica Sawhney | Roland Kölbl | Günter Hilger
Sitz der Gesellschaft: Batheyer Straße 115 - 117, 58099 Hagen
Postanschrift: Bürgermeister-Wegele-Str. 12, 86167 Augsburg
Amtsgericht Hagen HRB 13257
Steuernummer: 321/5800/1497